CAR T cell therapy has several potential benefits over conventional cancer treatments, including:
High Efficacy: CAR T cell therapy has demonstrated high response rates and durable remissions in patients with hematological malignancies. In clinical trials, up to 80% of patients with ALL achieved complete remission after CAR T cell therapy, and many of these patients remained disease-free for years.
Low Toxicity: Unlike chemotherapy and radiation, CAR T cell therapy is a targeted treatment that does not harm healthy cells. As a result, it has fewer side effects and is better tolerated by patients.
Personalized Treatment: CAR T cell therapy is a personalized treatment that uses a patient's own immune cells. This eliminates the risk of rejection and the need for immunosuppressive drugs.
Potential for Long-Term Protection: CAR T cell therapy has the potential to provide long-term protection against cancer. Once the immune system is activated, it can continue to recognize and attack cancer cells, leading to a sustained anti-cancer response.
Read More:
